Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 57 citing articles:

Engineering ionizable lipids for rapid biodegradation balances mRNA vaccine efficacy and tolerability
Julien Couture‐Senécal, Grayson Tilstra, Omar F. Khan
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses.
Alexander Bukreyev, Michelle Meyer, Bronwyn M. Gunn, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 3
Safety and immunogenicity of mRNA-based seasonal influenza vaccines formulated to include multiple A/H3N2 strains with or without the B/Yamagata strain in US adults aged 50–75 years: a phase 1/2, open-label, randomised trial
Denise C. Hsu, Akila Jayaraman, Alicia Pucci, et al.
The Lancet Infectious Diseases (2024)
Closed Access | Times Cited: 3
Comprehensive analysis of lipid nanoparticle formulation and preparation for RNA delivery
Md. Anamul Haque, Archana Shrestha, Constantinos M. Mikelis, et al.
International Journal of Pharmaceutics X (2024) Vol. 8, pp. 100283-100283
Open Access | Times Cited: 3
Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids
Johannes Bader, Finn Brigger, Jean‐Christophe Leroux
Advanced Drug Delivery Reviews (2024), pp. 115461-115461
Open Access | Times Cited: 3
Polymeric nanoparticle-based mRNA vaccine is protective against influenza virus infection in ferrets
Gijs Hardenberg, Chantal Brouwer, Rachelle van Gemerden, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 1, pp. 102159-102159
Open Access | Times Cited: 2
A 10-valent composite mRNA vaccine against both influenza and COVID-19
Yang Wang, Qinhai Ma, Man Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Towards broad-spectrum protection: the development and challenges of combined respiratory virus vaccines
Yang Wang, Xiaotong Wei, Yang Liu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
A decavalent composite mRNA vaccine against both influenza and COVID-19
Yang Wang, Qinhai Ma, Man Li, et al.
mBio (2024) Vol. 15, Iss. 9
Open Access | Times Cited: 2
Insights into the formulation of lipid nanoparticles for the optimization of mRNA therapeutics
Xiangyu Jiao, Xi He, Shugang Qin, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 5
Closed Access | Times Cited: 2
Optimising a linear ‘Doggybone’ DNA vaccine for influenza virus through the incorporation of DNA targeting sequences and neuraminidase antigen
Robert F. Cunliffe, David C. Stirling, Ilaria Razzano, et al.
Discovery Immunology (2024)
Open Access | Times Cited: 2
Recent Insights into the Molecular Mechanisms of the Toll-like Receptor Response to Influenza Virus Infection
Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama–Kohara
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5909-5909
Open Access | Times Cited: 2
Advances in Engineering Circular RNA Vaccines
Zhongyan Zhang, Yuanlei Fu, Xiaoli Ju, et al.
Pathogens (2024) Vol. 13, Iss. 8, pp. 692-692
Open Access | Times Cited: 2
Synthetic nanomaterials for spleen-specific mRNA delivery
Shihong Nie, Beiqi Yang, Ruiying Ma, et al.
Biomaterials (2024) Vol. 314, pp. 122859-122859
Closed Access | Times Cited: 1
Engineering a cleaved, prefusion-stabilized influenza B virus hemagglutinin by identification and locking of all six pH-switches
Jarek Juraszek, Fin Milder, Xiaodi Yu, et al.
PNAS Nexus (2024) Vol. 3, Iss. 10
Open Access | Times Cited: 1
Respiratory Virus Vaccines: Pathways to Recommendations and Enhanced Coverage for At-Risk Populations
Stefania Maggi, Odile Launay, Rachel Dawson
Infectious Diseases and Therapy (2024)
Open Access | Times Cited: 1
The Impact of Vaccination on COVID-19, Influenza, and Respiratory Syncytial Virus-Related Outcomes: A Narrative Review
Roberto Debbag, Deborah Rudin, Francesca Ceddia, et al.
Infectious Diseases and Therapy (2024)
Open Access | Times Cited: 1
mRNA-based influenza vaccine expands breadth of B cell response in humans
Hanover Matz, Tae-Geun Yu, Julian Q. Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Novel Influenza Vaccines: From Research and Development (R&D) Challenges to Regulatory Responses
Xiangchuan He, Tianxiang Zhang, Shitong Huan, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1573-1573
Open Access | Times Cited: 3
A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression
Huajun Zhao, Xianyu Shao, Yating Yu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Biotechnology Advances in Disease Treatment
Sooram Banesh, Surajbhan Sevda
Elsevier eBooks (2024), pp. 511-527
Closed Access
Estimates of Seasonal Influenza Burden That Could Be Averted by Improved Influenza Vaccines in the Australian Population Aged Under 65 Years, 2015–2019
Alicia Stein, Catherine GA Pendrey, David Muscatello, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 4
Open Access
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine
Benjamin J. Cowling, George N. Okoli
Drugs (2024) Vol. 84, Iss. 9, pp. 1013-1023
Open Access
Next-generation influenza vaccines based on mRNA technology
Irina Isakova–Sivak, Larisa Rudenko
The Lancet Infectious Diseases (2024)
Closed Access
Further therapeutic applications of mRNA and saRNA
Anya M Hillery
Elsevier eBooks (2024), pp. 187-216
Closed Access

Scroll to top